Showing 2,281 - 2,300 results of 15,188 for search '(( significantly increased decrease ) OR ( significantly ((linear decrease) OR (we decrease)) ))', query time: 0.61s Refine Results
  1. 2281
  2. 2282
  3. 2283
  4. 2284
  5. 2285
  6. 2286

    Increased CN inhibition leads to reduced STO frequency and to more CSpk frequency. by Elías M. Fernández Santoro (22470299)

    Published 2025
    “…(E) Increase in CN-to-IO inhibitory synapses, and thus inhibition strength, led to a decrease in IO STO frequency and a concurrent increase in CSpk frequency.…”
  7. 2287

    MXene/Bi<sub>2</sub>O<sub>3</sub> Nanocomposites as Supercapacitors for Portable Electronic Devices by Nanasaheb M. Shinde (8560572)

    Published 2025
    “…2D MXene nanosheets often encounter challenges such as aggregation and restacking, which can significantly decrease their performance in supercapacitor applications. …”
  8. 2288
  9. 2289
  10. 2290
  11. 2291
  12. 2292
  13. 2293
  14. 2294

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
  15. 2295

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
  16. 2296

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Postmenopausal osteoporosis (PMO) is characterized by an imbalance in bone remodeling with increased osteoclast and decreased osteoblast activity, leading to bone loss and higher fracture risk. …”
  17. 2297
  18. 2298
  19. 2299
  20. 2300